Please login to the form below
The Lancet
This page shows the latest The Lancet news and features for those working in and with pharma, biotech and healthcare.
Germany backs use of AZ/Oxford COVID-19 vaccine in over-65s
weeks. This recommendation was based on a study that showed that extending the time between doses improves the efficacy of the vaccine. ... The data, published in a preprint with The Lancet, reported that ‘vaccine efficacy was higher, after the second
Latest news
-
EMA begins rolling review process for Sputnik V COVID-19 vaccine
Late-stage trial results published in The Lancet found that the vaccine was 91.6% effective at protecting against COVID-19. ... We welcome the start of the rolling review procedure by EMA of Sputnik V.
-
AZ/Oxford University’s COVID-19 vaccine to be evaluated in children and young adults
The study, which launched last Friday, will begin the first vaccinations in February. ... New data, published in a preprint with The Lancet, reported that the efficacy of the ChAdOx1 nCoV-19 vaccine was higher after the second dose in those with a dosing
-
AZ refutes reports suggesting its COVID-19 vaccine is less effective in the elderly
German media reports suggested vaccine is less than 10% effective in the elderly. ... In response, AZ said that the reports were “completely incorrect”, further highlighting data published in The Lancet last November.
-
Trial combining British and Russian COVID-19 vaccines could begin in February
of the AZ/Oxford vaccine followed by the Russian vaccine on day 29 of the study. ... Last month, The Lancet published peer-reviewed results from an interim analysis of AZ/Oxford’s phase 3 COVID-19 vaccine programme, confirming the vaccine to be 70.4%
-
UK biotech Synairgen treats first patient in phase 3 COVID-19 trial
SNG001 delivers an inhaled formulation of Interferon-beta-1a directly to the lungs. ... The findings, published in The Lancet, also found that over the 14-day treatment period, patients in the SNG001 group were more than twice as likely to recover
More from news
Approximately 2 fully matching, plus 136 partially matching documents found.
Latest Intelligence
-
The search for effective drug treatments for COVID-19
In the context of a global pandemic, this timeline was reduced to months. ... They were coordinated by the China-Japan Friendship Hospital in Beijing. The results from the severe study was published in The Lancet.
-
Rethinking our approach to infectious disease preparedness
We’re not ready’. Gates said: “Today, the greatest risk of global catastrophe. ... According to a paper in The Lancet, early research has found that nearly 15% of all COVID-19 patients acquire deadly secondary bacterial infections.
-
How will COVID-19 affect uptake of vaccinations against other diseases?
Will COVID-19 help or hinder the quest to increase uptake of other vaccinations? ... Recent controversies surrounding the release of data on promising COVID-19 therapies in press releases prior to publication of detailed trial results, and the retraction
-
Industry needs an aligned position on the future of the EU OMP Regulation
In 2017, two serving Dutch ministers wrote in The Lancet that ‘the system is broken… companies can ask the price they like’. ... If the OMP Regulation is reopened, we may see a new law proposed by 2021.
-
Happy 70th birthday NHS: the next 70 need to be very different
Pharma joins in the congratulations – but conflicts will continue. Richard Horton, the editor of The Lancet, insists in a Guardian article that the NHS should no longer be viewed as a ... lead to poor health such as poverty, and upgrading the quality
More from intelligence
Approximately 0 fully matching, plus 9 partially matching documents found.
Latest appointments
-
Sudler London makes three senior hires
Boulding joins with more than 25 years of experience in the pharma industry, having worked in sales and marketing prior to moving into senior client roles in healthcare advertising agencies. . ... Pound, too, has significant medical communications and
-
ROCK names new managing director
His experience prior to Pollen includes the role of managing director for Cohn &Wolfe's healthcare business and senior business director at Ogilvy Healthworld. ... He also has experience at publishing firms The Lancet and Medpress.
More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.
Latest from PMHub
-
Addressing Climate Impact: The Healthcare Paradox
Observable effects of climate change are already being felt – for example, the Lancet’s 2019 report on the infection rates of dengue fever (expressed as vectorial capacity for transmissions) showed that ... In 2015 the global pharmaceutical industry
-
Fake News is Bad for your Health
Trust in vaccines fell as a result of emotional contagion, triggered by the 1998 publication of Andrew Wakefield's paper in the Lancet linking the MMR vaccine with autism and bowel ... But the majority of the public don't even read the mainstream media.
-
World Diabetes Day: Interaction and impact of diabetes on mental health
16. Snoek, F.J., Bremmer, M.A. and Hermanns, N., 2015. Constructs of depression and distress in diabetes: time for an appraisal. The Lancet Diabetes &Endocrinology, 3(6), pp.450-460. ... 22. Diabetes UK (2017) The Future of Diabetes
-
Focus on multiple myeloma treatment: Witnessing a transformation
opening of a recent editorial in the Lancet on multiple myeloma. ... This meant significant cost in terms of toxicity, and marginal impact on the overall survival of patients. .
-
Exploring MINT: Part 4 - Turkey
Public sector healthcare reforms. Turkey’s implementation of universal healthcare coverage has received considerable global acclaim. Notably in 2013, an article was published in the Lancet hailing the success of the ... The government has actively
More from PMHub
Approximately 0 fully matching, plus 6 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Freelance Medical Writer - Creative Healthcare Comms - 2 month t...
-
Excellent Day Rate
- Senior Account Director & Associate Director - Healthcare Ad...
-
Highly Competitive Salary, Bonus &Benefits
- FREELANCE Medical Writer, Senior Medical Writer, Principal Medic...
-
Highly Competitive Day Rate, Bonus &Benefits
- Editor & Senior Editor - Medical Communications - Home Based
-
Highly Competitive Salary, Bonus &Benefits
- Home Working Medical Copy Writer & Senior Medical Copy Write...
-
Highly Competitive Salary, Bonus &Benefits
- Senior Account / Programme Manager - MedComms - Buckinghamshire
-
Highly Competitive Remuneration packages
- Client Services Director – London or Home Based – Medical Commun...
-
Highly Competitive Salary, Bonus &Benefits
- Freelance Account Manager - Creative Healthcare Comms - Immediat...
-
Excellent Day Rate
- Senior Content Editor - Biotechnology
-
Salary TBC
-
Account Management
-
Competitive Salary Offered
- Medical Writer, Senior Medical Writer, Principal Medical Writer,...
-
Highly Competitive Salary, Bonus &Benefits
- Senior Leadership Role – Medical Communications – North West
-
Highly Competitive Salary, Bonus &Benefits
- AZ showcases data for next-generation PARP inhibitor AZD5305
- Sanofi pays $160m upfront to acquire Tidal Therapeutics
- GSK discontinues two feladilimab trials in head and neck cancer
- Novavax seeks FDA emergency approval for COVID-19 vaccine by May
- Pfizer/BioNTech say their COVID-19 vaccine can be stored at warmer temperatures
- FDA approves new self-injection administration for Xolair
- Lilly asks to revoke emergency authorisation for bamlanivimab monotherapy in the US
- CureVac outlines COVID-19 vaccine production plans ahead of regulatory approval
- Alexion and NICE agree confidential discount for Ultomiris use on the NHS
- Novartis’ MS therapy Kesimpta reduces risk of disability progression regardless of relapses
- Merck & Co halts development of potential COVID-19 drug MK-7110
- Virtually, the same: Is it time to rethink congress strategy?
PMHub
Havas Lynx Group
We are the Havas Lynx Group. Devoted to fresh thinking. Changing the way the world does healthcare communications for the...
Latest intelligence
- InSite Events™ National Pharma Meeting: A Customer Story
- How our client leveraged Impetus Digital’s white-glove service, 360° coverage and care, and award-winning InSite Events™ platform to successfully transfer their annual national meeting online....
- Fear or encouragement, which is best to drive behaviour change?
- The communications industry depends on fear of the perceived loss of something, in order to create the hope found in a product benefit. But, if if left too long unchecked,...
- The unheard, unseen, and uncorrected effects of COVID-19
- The disproportionate effects of the pandemic have been highlighted amongst ethnic minorities, so is it likely that ethnic minorities will be more worried about participating? And could this exacerbate inequalities...
Quick links
Infographics
